Comerica Bank Acadia Pharmaceuticals Inc Transaction History
Comerica Bank
- $24.4 Billion
- Q4 2024
A detailed history of Comerica Bank transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Comerica Bank holds 885 shares of ACAD stock, worth $14,859. This represents 0.0% of its overall portfolio holdings.
Number of Shares
885
Previous 716
23.6%
Holding current value
$14,859
Previous $11,000
45.45%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ACAD
# of Institutions
316Shares Held
164MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$720 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$234 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$203 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$146 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$123 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.72B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...